Phase I Pediatric FMP2.1/AS02A Trial in Mali

NCT00358332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

FED

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: FMP2.1/AS02A
BIOLOGICAL: Rabies vaccine (RabAvert)

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]